In a monumental shift for women’s health, polycystic ovary syndrome (PCOS) has been rebranded as polyendocrine metabolic ovarian syndrome (PMOS). This change, announced at the European Congress of Endocrinology in Prague, marks a significant achievement after more than a decade of global advocacy led by patients and medical professionals alike. The new term seeks to more accurately reflect the complex nature of the condition, which affects approximately one in eight women worldwide, or around 170 million individuals.
A New Era for Women’s Health
The change comes at a crucial time as health experts, including Professor Helena Teede from Melbourne’s Monash Centre for Health Research and Implementation, emphasise the need for a name that encompasses the broader implications of the syndrome. “The term PCOS has misled both patients and healthcare providers for far too long,” Teede stated during the announcement. “It reduces the condition to a singular focus on the ovaries, overlooking the metabolic and endocrine complications that significantly impact women’s health.”
Historically, the term “polycystic” has been a source of confusion, leading many patients to believe they must have cysts on their ovaries to receive a diagnosis. In reality, many individuals experience symptoms without visible cysts, highlighting the critical need for a name that encapsulates the syndrome’s multifaceted nature.
Patient Voices Drive Change
Maddy Mavrikis, a Sydney resident and one of over 300 individuals who shared their stories with Guardian Australia, exemplifies the struggles many face. Diagnosed with PCOS at age 15, Mavrikis recalls the initial prognosis suggesting infertility, a notion she later discovered to be incorrect. “I never had cysts, so I never understood why I was labelled with polycystic ovaries,” she explained. Her journey has been fraught with confusion, largely stemming from the inadequacies of the previous terminology.
The new name PMOS not only addresses misconceptions but also aims to alleviate the stigma associated with the condition. Mavrikis and other advocates have long argued for a name that accurately reflects the hormonal imbalances and their effects on various body systems, including metabolic health and the risk of diabetes and cardiovascular disease.
A Collaborative Effort
The renaming initiative has been a collaborative effort among 56 medical and patient societies from around the globe, marking a historic first in addressing patient perspectives in medical nomenclature. Teede noted that the commitment to change was driven by patients who have experienced the detrimental effects of the previous terminology. “They wanted it fixed,” she said, underscoring the power of patient advocacy in shaping medical discourse.
The process began with discussions and workshops, where healthcare professionals listened to patients’ experiences and insights. Lorna Berry, a long-time advocate for PCOS awareness, participated in these workshops, emphasising the importance of ensuring that the new name resonated with the lived experiences of those affected. “I felt like an equal in those discussions with professionals,” Berry said, illustrating the shift towards a more inclusive approach in medical conversations.
Looking Ahead
The new name will be officially adopted in the next update of international guidelines for managing the condition, anticipated in 2028. This transition period allows for the necessary adjustments in both medical and public understanding of PMOS. As more health professionals and the general public engage with the new terminology, there is hope for improved diagnosis, treatment, and support for those living with the condition.
Mavrikis remains optimistic about the future: “The name change represents a shift in attention towards a condition that has been neglected for too long. It brings hope for better care and deeper understanding of the complexities involved.”
Why it Matters
The renaming of PCOS to PMOS is not just a semantic change; it carries the potential to reshape the entire landscape of women’s health care. By embracing a name that accurately reflects the condition’s complexities, health professionals are more likely to adopt a holistic approach in treatment and support. As awareness grows, so too does the possibility of improved outcomes and a reduction in the stigma surrounding hormonal health issues. This change signals a new chapter in understanding and addressing the diverse needs of women globally, fostering a more empathetic and informed healthcare environment.
